SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-010611
Filing Date
2020-08-14
Accepted
2020-08-14 09:44:10
Documents
61
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q btai-20200630x10q.htm 10-Q 1266912
2 EX-10.1 btai-20200630ex101dd8d33.htm EX-10.1 278191
3 EX-10.3 btai-20200630ex103a23b2e.htm EX-10.3 89327
4 EX-10.4 btai-20200630ex104551247.htm EX-10.4 86260
5 EX-31.1 btai-20200630ex31138d5ca.htm EX-31.1 16301
6 EX-31.2 btai-20200630ex312df7ea0.htm EX-31.2 15401
7 EX-32.1 btai-20200630ex321cdc2fd.htm EX-32.1 9831
8 EX-32.2 btai-20200630ex3225653f9.htm EX-32.2 8199
  Complete submission text file 0001558370-20-010611.txt   4348303

Data Files

Seq Description Document Type Size
9 EX-101.INS btai-20200630.xml EX-101.INS 537996
10 EX-101.SCH btai-20200630.xsd EX-101.SCH 34911
11 EX-101.CAL btai-20200630_cal.xml EX-101.CAL 33105
12 EX-101.DEF btai-20200630_def.xml EX-101.DEF 101984
13 EX-101.LAB btai-20200630_lab.xml EX-101.LAB 318198
14 EX-101.PRE btai-20200630_pre.xml EX-101.PRE 228677
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38410 | Film No.: 201101873
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences